MITO logo

Stealth BioTherapeutics (MITO) Cash From Investing

Annual CFI

$183.00 K
+$243.00 K+405.00%

December 31, 2021

Summary

Performance

1-Year Change

+405%

3-Year Change

+1625%

5-Year Change

+205.78%

15-Year Change

+205.78%

MITO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$183.00 K
MITO annual cash flow from investing activities is currently at an all-time high

3-Year Low

$183.00 K
MITO annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
MITO previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
MITO next annual earnings announcement has not yet been scheduled

OtherMITOcash flowmetrics:

Annual CFF

$59.14 M
MITO annual cash flow from financing activities is $59.14 million

Annual CFO

-$44.97 M
MITO annual cash flow from operations is -$44.97 million

Annual FCF

-$45.04 M
MITO annual free cash flow is -$45.04 million

Annual CAPEX

-
MITO annual capital expenditures value is unknown

Quarterly CFI

N/A

March 31, 2022

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

MITO Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$245.00 K
MITO quarterly cash flow from investing activities is currently at an all-time high

3-Year Low

-
MITO quarterly cash flow from investing activities 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
MITO previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
MITO next earnings announcement has not yet been scheduled

OtherMITOcash flowmetrics:

Quarterly CFF

-
MITO quarterly cash flow from financing activities value is unknown

Quarterly CFO

-
MITO quarterly cash flow from operations value is unknown

Quarterly FCF

-
MITO quarterly free cash flow value is unknown

Quarterly CAPEX

-
MITO quarterly capital expenditures value is unknown

TTM CFI

N/A

March 31, 2022

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

MITO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$205.00 K
MITO TTM cash flow from investing activities is currently at an all-time high

3-Year Low

-
MITO TTM cash flow from investing activities 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
MITO previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
MITO next earnings announcement has not yet been scheduled

OtherMITOcash flowmetrics:

TTM CFF

-
MITO TTM cash flow from financing activities value is unknown

TTM CFO

-
MITO TTM cash flow from operations value is unknown

TTM FCF

-
MITO TTM free cash flow value is unknown

TTM CAPEX

-
MITO TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

MITO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+405.0%--
3 y3 years+1625.0%--
5 y5 years+205.8%--

MITO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low
5 y5-yearat high-171.0%
alltimeall timeat high-199.7%

Stealth BioTherapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2021
$183.00 K(-405.0%)
-
-
Jun 2021
-
$245.00 K(-712.5%)
$205.00 K(-479.6%)
Dec 2020
-$60.00 K(-53.8%)
-
-
Sep 2020
-
-$40.00 K(+185.7%)
-$54.00 K(-62.5%)
Jun 2020
-
-$14.00 K
-$144.00 K
DateAnnualQuarterlyTTM
Dec 2019
-$130.00 K(+983.3%)
-
-
Sep 2019
-
-$130.00 K(+1011.1%)
-$130.00 K(+1011.1%)
Dec 2018
-$12.00 K(-93.1%)
-
-
Sep 2018
-
-$11.70 K
-$11.70 K
Dec 2017
-$173.00 K(-5.2%)
-
-
Dec 2016
-$182.50 K
-
-

FAQ

  • What is Stealth BioTherapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Stealth BioTherapeutics?
  • What is Stealth BioTherapeutics annual CFI year-on-year change?
  • What is the all time high quarterly CFI for Stealth BioTherapeutics?
  • What is the all time high TTM CFI for Stealth BioTherapeutics?

What is Stealth BioTherapeutics annual cash flow from investing activities?

The current annual CFI of MITO is $183.00 K

What is the all time high annual CFI for Stealth BioTherapeutics?

Stealth BioTherapeutics all-time high annual cash flow from investing activities is $183.00 K

What is Stealth BioTherapeutics annual CFI year-on-year change?

Over the past year, MITO annual cash flow from investing activities has changed by +$243.00 K (+405.00%)

What is the all time high quarterly CFI for Stealth BioTherapeutics?

Stealth BioTherapeutics all-time high quarterly cash flow from investing activities is $245.00 K

What is the all time high TTM CFI for Stealth BioTherapeutics?

Stealth BioTherapeutics all-time high TTM cash flow from investing activities is $205.00 K